Close
ACHEMA MIDDLE EAST 2026
Pharmtech & Ingredients

News

      Bayer, NextRNA Collaborate On $547Million Cancer Drug Deal

      Drug Development
      Bayer and NextRNA Therapeutics, a biotechnology company, announced that they would be working together to create a new type of small molecule cancer drug....

      Enhancing CLD For Complex Biologics: Important Strategies

      Drug Development
      The capacity of a cell line to create a biologic that is both safe and stable in large numbers may be considerably improved by...

      North American Nuclear Medicine Market Set For Expansion

      Drug Development
      The North American nuclear medicine market was estimated to be worth USD 2.05 billion in 2023 and is expected to develop rapidly over the...

      Bayer, NextRNA Ink $547Million Deal For Cancer Therapies

      Drug Development
      This summer, Bayer officials made sure Fierce understood that the company's desire for deals hasn't been stifled by a group-wide reorganization. Its most recent...

      New Endometrial Cancer Care Phase II Results Encouraging

      Clinical Trials
      The most recent trial of a new antibody drug that goes on to deliver potent chemotherapy that too directly to the cancer cells for...

      Duality Keeps An Eye Out For Hong Kong IPO For ADC Trials

      Clinical Trials
      Duality Biotherapeutics from China has gone ahead and filed paperwork as far as a Hong Kong IPO is concerned, thereby looking out for an...

      Siemens Healthineers, Novartis Partner To Grow PET Imaging

      IPR Data Management
      In a recent development taking place in the last week of August 2024, Siemens Healthineers has gone ahead and agreed to pay over 200...

      Subscribe Our Newsletter

      White Papers

      The Future of Digital Health

      Whitepapers 0
      The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

      Five Best Practices to Deliver Exceptional Multichannel Experiences

      Whitepapers 0
      A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

      The Impact and Use of Social Media in Pharmacovigilance

      Whitepapers 0
      Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...

      About us

      Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

      System

      Resources

      Subscribe

      © 2025 Copyright © Valuemediaservices 2025 All rights reserved.